Pediatric News - FDA Panel Backs OTC Status of Allergy Drugs.

An advisory panel of the US Food and Drug Administration (FDA) has voted overwhelmingly that three allergy remedies–loratadine, cetirizine, and fexofenadine–are safe enough to be bought at pharmacies and supermarkets without a doctor’s prescription. But the manufacturers of the drugs, marketed in the United States as Claritin, Zyrtec, and Allegra, are resisting the idea.
Wellpoint Health Networks, a large Californian insurer, successfully argued before the FDA panel that all three drugs are safer than many of the other allergy drugs that are already sold over the counter.
Dr John Jenkins, director of the FDA office that evaluates anti-allergy drugs, said: “We have not identified any serious safety concerns with any of these drugs. neurontin. ”

Related Results

OTC drug makers seek FDA approval of generic Claritin

New Benadryl[R] One A Day Relief to drive sales in grocery no one-a-day aller…

Wicked Itch of the West

Efficacy and central nervous system impairment of newer-generation prescripti…

Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoep…

But the makers of the drugs argue that Wellpoint is trying to save money by shifting the cost from insurers to patients. Wellpoint has said that it would save $45m (32m [pounds sterling]) a year if the drugs were available over the counter.
COPYRIGHT 2001 British Medical Association
COPYRIGHT 2008 Gale, Cengage Learning

source